Clinical trials

CLINICAL TRIALS

Clinical trials

  • 1

    clinical study ongoing
    in patients

  • 7

    clinical trials
    completed

  • 679

    people enrolled so far in phase 1 and phase 2
    clinical trials

  • 496

    people exposed to DAV132

We are currently conducting the following clinical study:

StudyPhaseObjectivesLinks
MICROCAREPhase 3A multicenter, randomized, placebo-controlled, parallel-arm clinical trial to evaluate the efficacy of DAV132 in patients with newly-diagnosed Acute Myeloid Leukemia or high-risk Myelodysplastic Syndrome treated with intensive chemotherapy.

The following clinical trials have been completed:

StudyPhaseObjectivesLinks
DAV132-CL-2001
SHIELD Study
Phase 2Evaluate the safety and efficacy of DAV132 during fluoroquinolones treatment in hospitalized elderly patients with comorbidities ClinicalTrials.gov
Press Release
DAV132-CL-1006Phase 1Evaluate the safety and efficacy of DAV132 during 5 days of IV beta-lactam treatments
DAV132-CL-1004Phase 1Evaluate the safety and efficacy of different regimens of DAV132 with moxifloxacin as a model antibioticClinicalTrials.gov
Poster
DAV132-CL-1003
DAV132-CL-1005
Phase 1Drug-drug interaction study to characterized the influence of DAV132 on pharmacokinetic parameters of concomitant drugs Press Release
Article
DAV132-CL-1002Phase 1Evaluate the safety and efficacy of DAV132 during 5 days of oral moxifloxacin treatmentClinicalTrials.gov
Poster
Article
DAV132-CL-1001Phase 1Validate the mode of action of the colon-targeted release Poster
Article